英文别名 |
Etodolac;1,8-DIETHYL-1,3,4,9-TETRAHYDROPYRANO[3,4-B]INDOLE-1-ACETIC ACID;1,8-DIETHYL-1,3,4,9-TETRAHYDRO-PYRANO[3,4-B]INDOLE-1-ACETIC ACID;rac-Etodolac;Edolan;Etodlic acid;etodolic acid;Etopen;Hypen;Lodine;RAK-591;Ramodar;Tedolan;Ultrado;Zedolac;NSC 282126;AY-24236;GTPL7185;ETODOLAC [INN];Pyrano(3,4,b)indole-1-acetic acid, 1,3,4,9-tetrahydro-1,8-diethyl-;DB00749;Prestwick3_000231;ETODOLAC (EP MONOGRAPH);HMS2231D04;KBio2_001724;Etodolac (JP17/USP/INN);NSC-757821;NCGC00015399-26;NCGC00089769-04;AB00052194;AY-24-236;E 0516;FT-0668425;DTXSID9020615;2-((1RS)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indol-1-yl)acetic acid;ETODOLAC (USP MONOGRAPH);Tox21_202218;Etodolacum (INN-Latin);Ultradol;Pyrano[3,4-b]indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-;D00315;HMS3259P10;MLS006011566;HMS2092O20;NCGC00089769-03;NCGC00089769-06;ETODOLAC [GREEN BOOK];KBioSS_001724;FT-0607046;ETODOLAC [EP MONOGRAPH];Tox21_110644;Flancox;NCGC00015399-16;(+/-)-1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid;HY-76251;NSC282126;Q2465218;(+-)-1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid;HMS2095P03;Etodolac for peak identification, European Pharmacopoeia (EP) Reference Standard;HMS1921B09;KBio3_002358;Opera_ID_1774;(rs)-etodolic acid;Etogesic Sterile Injectable Solution;NS00010209;Pyrano(3,4-b)indole-1-acetic acid, 1,3,4,9-tetrahydro-1,8-diethyl-;Pyrano(3,4-b)indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-;BPBio1_000333;Pyrano[3, 1,8-diethyl-1,3,4,9-tetrahydro-;CS-0832;ETODOLAC [MI];KBio2_004292;CCG-39005;KBio2_006860;IDI1_000147;NINDS_000147;HMS3712P03;Prestwick0_000231;ETODOLAC [JAN];KBio1_000147;AY-24,236;Lopac0_000479;1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid;Etogesic;BRD-A74667430-001-05-3;SR-01000000100-7;EtoGesic Tablets;Etodolac, European Pharmacopoeia (EP) Reference Standard;M01AB08;Etodolac, United States Pharmacopeia (USP) Reference Standard;NSC-282126;Osteluc;SR-01000000100;Lodin xl;Etodolac [USAN:USP:INN:BAN];NCGC00015399-05;ETODOLAC [USP MONOGRAPH];NCGC00015399-07;ETODOLAC [ORANGE BOOK];Etodolac Assay Standard;Etodolsaure;E0858;BRD-A74667430-001-15-2;C06991;NSC757821;Eccoxolac;EtodolacER;AY 24,236; AY 24236;AY-24,236; AY-24236; AY24,236; AY24236;Etodolac for peak identification;Lodine XL;(1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indol-1-yl)-acetic acid;NIH-9918;Tox21_500479;ETODOLAC [USAN];BSPBio_003138;41340-25-4;ETODOLAC [VANDF];(1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid;1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indol-1-ylacetic acid;Etodolaco [INN-Spanish];SY057989;Spectrum2_001387;Prestwick1_000231;1,8-Diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid;NCGC00089769-07;1,8-DIETHYL-1,3,4,9-TETRAHYDROPYRANO(3,4-B)INDOL-1-ACETIC ACID;Etodolacum;UNII-2M36281008;CHEMBL622;HMS1568P03;AC-4231;MLS000028474;Lodine (TN);Pyrano(3,4-b)indole-1-acetic acid, 1,8-dieth... |